Nanome, founded in 2015, revolutionizes scientific discovery through its immersive virtual reality (VR) platform. Dubbed the "ultimate interface" for molecular data, it facilitates top-tier research, empowering R&D labs to make significant, billion-dollar decisions. Enthusiasts—from professional scientists to students—leverage Nanome to build intricate 3D molecules and simulate entire proteins within a collaborative environment.
Deployed on devices like the Meta Quest Pro, Nanome intertwines education with innovation, enhancing the user experience in AI, Biopharma, Biotechnology, and VR/AR sectors. The company is headquartered in the United States, and it secured a Series A investment on 01 August 2022, backed by Navigate Ventures, LLC. This investment serves as a testament to its growth potential in transforming molecular education and research.